Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

FDA Approves Sculptra(R)Aesthetic, A Facial Injectable For Correction Of Nasolabial Folds And Other Facial Wrinkles
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved Sculptra(R)Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy patients. Sculptra(R)Aesthetic works gradually to offer natural-looking results that can last up to two years.
generic viagra online
Phase II Study Of Sunitinib In Men With Advanced Prostate Cancer
UroToday.com - In the Annals of Oncology, Dr. Dror Michaelson and associates reported Phase II data on the efficacy and safety of the tyrosine kinase inhibitor sunitinib in patients with castration-resistant prostate cancer (CRPC). Sunitinib inhibits vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), both elevated in prostate cancer (CaP).
News of the day
Prostate Cancer Screening And Trust Of Physician Evaluated
Trusted health care s and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer. James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute (RPCI), and William R. Carpenter, PhD, Department of Health Policy and Management at the University of North Carolina, are lead investigators.
Cardiovascular

Uganda's Health Ministry Orders Investigations Into Deaths Of Patients Living With HIV

Uganda"s Health Ministry announced Monday it has ordered investigations into whether the deaths of 17 patients living with HIV in Northern Uganda were caused by their inability to get antiretroviral (ARV) drugs, the AP/mlive.com reports. According to Zainab Akol, manager of the ministry"s HIV/AIDS control program, the ministry is exploring "whether apart from the lack of ARVs, another disease like malaria or any epidemic could have contributed to the deaths," according to the news service. The article examines assertions that Uganda is exepriencing a shortage of antiretrovirals. Akol "attributed the shortage of antiretroviral drugs to a sharp increase this year in the number of AIDS patients," after a countrywide testing campaign identified 100,000 addition HIV-positive people. "The number of HIV/AIDS patients increased yet money provided by donors to buy the drugs did not increase," said Akol. The article includes comments by Stephen Watiti of Uganda"s National Forum of People Living with HIV-AIDS Network, who "said his group has also received reports about the 17 HIV patients dying in northern Uganda and is investigating whether patients in other areas of the country are affected." Watiti commented that some government health centers has stopped providing antiretrovirals to HIV-positive patients and that treatment interruption "could expose Uganda to "an explosion of a new HIV epidemic that is predominantly drug resistant"" (Olukya, 7/27). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009